Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to current ...
Renatus Tactical Acquisition Corp I does not have significant operations. The company intends to effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar ...
Renatus Tactical Acquisition Corp. I is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback